Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response.
Conery AR, Centore RC, Spillane KL, Follmer NE, Bommi-Reddy A, Hatton C, Bryant BM, Greninger P, Amzallag A, Benes CH, Mertz JA, Sims RJ 3rd.
Conery AR, et al. Among authors: centore rc.
Cancer Res. 2016 Mar 15;76(6):1313-9. doi: 10.1158/0008-5472.CAN-15-1458. Epub 2016 Jan 12.
Cancer Res. 2016.
PMID: 26759243